Study Suggests Serotonin Not a Useful Target for PAH
Despite years of scientific attention and strong preclinical data, a new report casts doubt on the potential utility of serotonin as a target for the treatment of pulmonary arterial hypertension (PAH). The report found a drug designed to reduce peripheral …